Goldman Sachs Maintains Buy on Intuitive Surgical, Lowers Price Target to $609

Benzinga Newsdesk www.benzinga.com Negative 76.5%

Neg 76.5% Neu 0% Pos 0%

Goldman Sachs analyst David Roman maintains Intuitive Surgical (NASDAQ:ISRG) with a Buy and lowers the price target from $714 to $609.